Evidence map›Paper›PMID 38475733›Full record

ArticleCellular & molecular biology letters2024

The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice.

Tiantian Xu, Yan Pan, Qinchao Ding, Feiwei Cao, Kaixin Chang, Jiannan Qiu, Hui Zhuge, Liuyi Hao, Haibin Wei, Caijuan Si and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tiantian Xu *School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Yan Pan *School of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Qinchao Ding *School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Feiwei CaoSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Kaixin ChangSchool of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Jiannan QiuSchool of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Hui ZhugeSchool of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Liuyi HaoSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Haibin WeiSchool of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Caijuan SiDepartment of Clinical Nutrition, School of Medicine, Affiliated Zhejiang Hospital, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Xiaobing DouSchool of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Songtao LiSchool of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China. lisongtao@zcmu.edu.cn.
Zhejiang Chinese Medical University · CNZhejiang Hospital · CN

Funding

National Natural Science Foundation of China 81973041National Natural Science Foundation of China 82103838National Natural Science Foundation of China 82103839National Natural Science Foundation of China 82273625Natural Science Foundation of Zhejiang Province LR20H260001Natural Science Foundation of Zhejiang Province LZ21H030001Postgraduate Scientific Research Fund of Zhejiang Chinese Medical University 2022YKJ17
6 · The paper itself

Abstract

BACKGROUND AND

aimsEpidemiological evidence suggests that the phenotype of glutathione S-transferase mu 1 (GSTM1), a hepatic high-expressed phase II detoxification enzyme, is closely associated with the incidence of alcohol-related liver disease (ALD). However, whether and how hepatic GSTM1 determines the development of ALD is largely unclear. This study was designed to elucidate the role and potential mechanism(s) of hepatic GSTM1 in the pathological process of ALD.

methodsGSTM1 was detected in the liver of various ALD mice models and cultured hepatocytes. Liver-specific GSTM1 or/and micro (miR)-743a-3p deficiency mice were generated by adenoassociated virus-8 delivered shRNA, respectively. The potential signal pathways involving in alcohol-regulated GSTM1 and GSTM1-associated ALD were explored via both genetic manipulation and pharmacological approaches.

resultsGSTM1 was significantly upregulated in both chronic alcohol-induced mice liver and ethanol-exposed murine primary hepatocytes. Alcohol-reduced miR-743a-3p directly contributed to the upregulation of GSTM1, since liver specific silencing miR-743a-3p enhanced GSTM1 and miR-743a-3p loss protected alcohol-induced liver dysfunctions, which was significantly blocked by GSTM1 knockdown. GSTM1 loss robustly aggravated alcohol-induced hepatic steatosis, oxidative stress, inflammation, and early fibrotic-like changes, which was associated with the activation of apoptosis signal-regulating kinase 1 (ASK1), c-Jun N-terminal kinase (JNK), and p38. GSTM1 antagonized ASK1 phosphorylation and its downstream JNK/p38 signaling pathway upon chronic alcohol consumption via binding with ASK1. ASK1 blockage significantly rescued hepatic GSTM1 loss-enhanced disorders in alcohol-fed mice liver.

conclusionsChronic alcohol consumption-induced upregulation of GSTM1 in the liver provides a feedback protection against hepatic steatosis and liver injury by counteracting ASK1 activation. Down-regulation of miR-743a-3p improves alcohol intake-induced hepatic steatosis and liver injury via direct targeting on GSTM1. The miR-743a-3p-GSTM1 axis functions as an innate protective pathway to defend the early stage of ALD.

Indexed as

Fatty Liver, AlcoholicGlutathione TransferaseMicroRNAsAnimalsHepatocytesLiverMiceGlutathione TransferaseMicroRNAsMirn743 microRNA, mouseAlcohol-related liver diseaseASK1GSTM1Hepatic steatosismiR-743a-3p

Identifiers

PMID38475733
PMCPMC10936097
OpenAlexW4394739193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.